What We Offer
Our Products
FebriDx®
Product Overview
Introducing FebriDx®, FIRST EVER, Rapid Point-of-Care Test that aids in the diagnosis of bacterial acute respiratory infections and differentiates between bacterial infection and non-bacterial etiology. It allows the medical provider to rule out bacterial infections.
- Differentiates from non-bacterial etiology in patients
- 99% Negative predictive value
- Allows medical providers to rule out bacterial infections
- Reduces the need to write antibiotic prescriptions for patients
- Instrumental in limiting the spread of antibiotic-resistant bacteria
- Assists providers in determining when to initiate the correct treatment
- Delivers results within 15 minutes
- No equipment necessary
- CLIA Moderate Waived Test
RCS Healthcare: Our Vision